Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation

Ischemia reperfusion (I/R) injury is a leading cause of acute kidney injury with high morbidity and mortality due to limited therapy. NMDA receptor inhibitor (DAP5) and resveratrol (Res) could ameliorate kidney I/R injury, but their use is limited by low aqueous solubility and poor stability. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yong, Zhang, Bo, Xie, Da, Hu, Yu, Li, Hai-Lun, Zhong, Li-Li, Wang, Hong-Wu, Jiang, Wei, Ke, Zun-Ping, Zheng, Dong-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503631/
https://www.ncbi.nlm.nih.gov/pubmed/28465474
http://dx.doi.org/10.18632/oncotarget.17135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503631/
https://www.ncbi.nlm.nih.gov/pubmed/28465474
http://dx.doi.org/10.18632/oncotarget.17135

Ejemplares similares